Literature DB >> 1353145

Thrombolytic therapy for patients with myocardial infarction presenting after six hours.

H D White1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353145     DOI: 10.1016/0140-6736(92)90478-l

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The Open Artery Hypothesis: Past, Present, and Future.

Authors:  M Goel; J T Dodge; M Rizzo; C McLean; K A Ryan; W L Daley; C P Cannon; C M Gibson
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

2.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

Review 3.  How sound is the evidence that thrombolysis increases the risk of cardiac rupture?

Authors:  D R Massel
Journal:  Br Heart J       Date:  1993-04

Review 4.  Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.

Authors:  K S Woo; H D White
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

Review 5.  Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Authors:  P E Battershill; P Benfield; K L Goa
Journal:  Drugs Aging       Date:  1994-01       Impact factor: 3.923

Review 6.  Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?

Authors:  E Boersma; E W Steyerberg; M J Van der Vlugt; M L Simoons
Journal:  Drugs       Date:  1998-07       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.